NPI: 1396760542 · LIVINGSTON, TN 38570 · Rural Acute Care Hospital · NPI assigned 07/12/2006
Authorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
| Authorized Official | TRAYLOR, JOHNETTA (DIRECTOR LICENSE AND CERTIFICATION) |
| NPI Enumeration Date | 07/12/2006 |
Other providers sharing the same authorized official: TRAYLOR, JOHNETTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,887 | $474K |
| 2019 | 17,877 | $625K |
| 2020 | 16,250 | $522K |
| 2021 | 18,478 | $710K |
| 2022 | 19,504 | $733K |
| 2023 | 20,112 | $709K |
| 2024 | 12,575 | $559K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,697 | 13,189 | $1.53M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,339 | 10,054 | $1.03M |
| 87631 | 3,414 | 2,919 | $432K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,882 | 4,227 | $312K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,113 | 1,688 | $188K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,178 | 3,341 | $105K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,108 | 2,738 | $98K |
| 71045 | Radiologic examination, chest; single view | 3,260 | 2,703 | $89K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,962 | 12,904 | $71K |
| 71046 | Radiologic examination, chest; 2 views | 921 | 779 | $50K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,067 | 850 | $44K |
| 80053 | Comprehensive metabolic panel | 11,216 | 8,979 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 677 | 513 | $28K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 604 | 528 | $27K |
| 84484 | 3,513 | 2,618 | $26K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 435 | 367 | $26K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,069 | 949 | $25K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 93 | 74 | $24K |
| 70450 | Computed tomography, head or brain; without contrast material | 545 | 442 | $21K |
| 83605 | 3,240 | 2,527 | $17K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 175 | 165 | $13K |
| G0378 | Hospital observation service, per hour | 153 | 122 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,200 | 1,009 | $11K |
| 87400 | 1,434 | 1,255 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,487 | 2,081 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 311 | 283 | $9K |
| 81001 | 7,116 | 5,797 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,465 | 1,173 | $7K |
| 81005 | 4,964 | 4,088 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 368 | 290 | $6K |
| 80306 | 306 | 253 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 398 | 349 | $5K |
| 86900 | 168 | 149 | $5K | |
| 82803 | 672 | 501 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 67 | 55 | $4K |
| 87653 | 141 | 134 | $4K | |
| 59025 | Fetal non-stress test | 33 | 24 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 44 | 40 | $3K |
| 87430 | 271 | 241 | $3K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 172 | 113 | $3K |
| 83690 | 410 | 328 | $2K | |
| 36600 | 31 | 25 | $2K | |
| 81025 | 453 | 386 | $2K | |
| 87040 | 285 | 170 | $2K | |
| 82150 | 301 | 231 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 709 | 597 | $1K |
| 85379 | 225 | 175 | $876.38 | |
| 94060 | 20 | 12 | $848.04 | |
| 85730 | 433 | 315 | $842.68 | |
| 87070 | 84 | 76 | $796.22 | |
| J2704 | Injection, propofol, 10 mg | 568 | 500 | $776.28 |
| 85610 | 596 | 443 | $768.59 | |
| 86141 | 181 | 140 | $742.23 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 44 | 32 | $600.00 |
| 86901 | 168 | 149 | $590.75 | |
| 83735 | 173 | 141 | $505.91 | |
| 74022 | 41 | 36 | $473.62 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 358 | 304 | $456.02 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 44 | 32 | $437.57 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 556 | 467 | $415.49 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,330 | 1,941 | $359.84 |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 57 | 24 | $333.93 |
| 83880 | 63 | 49 | $266.56 | |
| 84145 | 16 | 13 | $161.78 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 56 | 52 | $161.60 |
| 82728 | 56 | 41 | $111.22 | |
| 87081 | 14 | 13 | $43.87 | |
| 83615 | 45 | 30 | $31.25 | |
| 87186 | 13 | 13 | $29.46 | |
| 87077 | 13 | 13 | $27.21 | |
| 82550 | 14 | 12 | $26.51 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19 | 13 | $21.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 14 | 13 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 15 | 12 | $0.00 |